Search in:

Advanced search

Current Opinion on Therapeutic Patents Volume 2, 1992 - Issue 8

Journal homepage

Views

CrossRef citations to date

Altmetric

CNS Agents

Patent Update: Agents for the Treatment of Alzheimer's Disease: Recent Patent Advances January to June, 1992

Wendell Wilkie Wilkerson DuPont Merck Pharmaceutical Company, Central Nervous System Disease Research, E353/347, The Experimental Station, Wilmington, DE, 19880-0353, USA

Pages 1223-1238 | Published online: 02 Mar 2011

Cite this article
https://doi.org/10.1517/13543776.2.8.1223

References
Citations
Metrics
Reprints & Permissions

References to Primary Literature

Becker, RE Giacobini, E Mechanism of cholinesterase inhibition in senile dementia of the Alzheimer type: Clinical, pharmacological, and therapeutic aspects. Drug Dev. Res. 1988 12 163–195.
Web of Science ®Google Scholar
Francis, PT Neurochemical studies on early-onset Alzheimer's disease. N. Engl. J. Med. 1985 313 7–11.
PubMed Web of Science ®Google Scholar
Hardy, J Molecular classification of Alzheimer's disease Lancet 1991 337 1342–1343.
Web of Science ®Google Scholar
Roberts, GW Gentleman, SM Lynch, A Graham, DI βA4 Amyloid protein deposition in brain after head trauma. Lancet 1991 338 1422–1423.
PubMed Web of Science ®Google Scholar
Eagger, SA Levy, R Sahakian, BJ Tacrine in Alzheimer's disease. Lancet 1991 337 989–992.
PubMed Web of Science ®Google Scholar
Growdon, JH Corkin, S Huff, FJ Rosen, TJ Piracetam combined with lecithin in the treatment of Alzheimer's disease. Neurobiol. Aging 1986 7 269–276.
PubMed Web of Science ®Google Scholar
Bartus, RT Drugs to treat age-related neurodegenerative problems. JAGS 1990 38 680–695.
PubMed Web of Science ®Google Scholar
Selkoe, DJ Amyloid protein and Alzheimer's disease. Sci. Amer. 1991 68–78.
Google Scholar
Sarter, M Taking stock of cognition enhancers. Trends Pharmacol. Sci. 1991 12 456–461.
PubMed Web of Science ®Google Scholar
Royston, MC Rothwell, NJ Roberts, GW Alzheimer's disease: Pathology and potential treatments? TIPS 1992 13 131–133.
PubMed Web of Science ®Google Scholar
Gandy, S Greengard, P Amyloidogenesis in Alzheimer's disease: Some possible therapeutic opportunities. TIPS 1992 13 108–113.
PubMed Web of Science ®Google Scholar
Flood, JF Morley, JE Roberts, E Amnestic effects in mice of four synthetic homologous to amyloid βprotein from patients with Alzheimer disease. Proc. Natl. Acad. USA 1991 88 3363–3366.
PubMed Web of Science ®Google Scholar
Wiseman, EJ Jarvik, LF Potassium channel blockers: Could they work in Alzheimer's disease? Alzheimer Disease and Associated Disorders 1991 5 25–30.
PubMed Web of Science ®Google Scholar
Sherman, KA Effect of oral administration of reversible inhibitors of blood acetylcholinesterase in humans: E2020 and tacrine. Soc. Neurosci. 1991 17 11.
Google Scholar
Sherman, KA New methods to determine in vivo action of reversible acetylcholinesterase inhibitors: Tacrine and E2020. Soc. Neurosci. 1991 16.
Google Scholar
E2020. Drugs Future 1991 16 16.
Google Scholar
E2020. Drugs Future 1992 17 56.
Google Scholar
Sherman, KA Harms, KF Measuring the effects of reversible acetylcholine sterase inhibitors by ex vivo assay. Pharmacologist 1990 32 102.
Google Scholar
Brufani, M Maurizio, M Pomponi, M Acetylcholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type disease. Eur. J. Biochem. 1986 157 115.
PubMedGoogle Scholar
Thai, LT Fuld, PA Memory ehancement with oral physostigmine in Alzheimer's disease. N. Engl. J. Med. 1983 308 720.
PubMedGoogle Scholar
Kozikowski, AP Delineating the pharmacophoric elements of huperzine-A: Importance of the unsaturated three-carbon bridge to its AChE inhibitory activity. J. Med. Chem. 1991 34 3399–3402.
PubMed Web of Science ®Google Scholar
Paterson, IA Juorio, AV Berry, MD Zhu, MY Inhibition of monoamine oxidase-B by (–)-deprenyl potentiates neuronal responses to dopamine agonist but does not inhibit dopamine catabolism in rat stratum. J. Pharmacol. Exp. Ther. 1991 258 1019–1026.
PubMed Web of Science ®Google Scholar
Chen, YL Synthesis, resolution, and structure-activity-relationships of potent acetylcholinesterase inhibitors: 8-Carbaphysostigmine analogues. J. Med. Chem. 1992 35 1429.
PubMed Web of Science ®Google Scholar
Fink, DM Allen, RC Synthesis and carbamoylation of 1,2,3,4,5,6-hexahydro-1,3,-diemthyl-2,6-methano-1,3-benzodiazcin-8-ol: Bridged analogues of physostigmine. Tetrahedron Lett. 1992 33 2103.
Web of Science ®Google Scholar
Sunderland, T Molchan, S Vitiello, B Martinez, R Martin, A Cholinergic Basis for Alzheimer Therapy Becker, R, Giacobini, E Birkhauser, Boston 1991 172–182.
Google Scholar
Giacobini, E Linville, D Messamore, E Ogane, N Cholinergic Basis for Alzheimer Therapy Becker, R, Giacobini, E Birkhauser, Boston 1991 477–490.
Google Scholar
Israel, M Manaranche, R Mastour-Frachon, P Morel, N Isolation of pure cholinergic nerve endings from the electric organ of Torpedo marmorata. Biochem. J. 1976 160 113–115.
PubMed Web of Science ®Google Scholar
Saunders, J Synthesis and characterization of all four isomers of the muscarinic agonist 2′-methylspiro[1-azabicyclo[2.2.2] octane-3,4′-[1,3]dixolane]. J. Med. Chem. 1987 30 969–975.
PubMed Web of Science ®Google Scholar
Tam, SW Rominger, D Nickolson, VJ Novel receptor site involved in enhancement of stimulus-induced acetylcholine, dopamine, and serotonin release. Mol. Pharmacol. 1991 40 16–21.
PubMed Web of Science ®Google Scholar
Cook, L Nickolson, VJ Steinfels, GF Rohrbach, KW DeNoble, VJ Cognition enhancement by the acetylcholine releaser DuP996. Drug Dev. Res. 1990 19 301–324.
Web of Science ®Google Scholar
Altman, HJ Normile, HJ Enhancement of the memory of a previously learned aversive habit following pre-test administration of a variety of serotonergic antagonists in mice. Psychopharmacol. 1986 90 24–27.
PubMed Web of Science ®Google Scholar
DeNoble, VJ DeNoble, KF Spencer, KR Protection against hypoxla-induced passive avoidance deficits: Interaction between DuP996 and ketanserin. Brain Res. Bull. 1991 26 817–820.
PubMed Web of Science ®Google Scholar
Rothman, SM Olney, JW TINS 1987 10 229.
Web of Science ®Google Scholar
Maragos, W Greenamyre, J Penney, J Jr Young, A TINS 1987 10 65.
Web of Science ®Google Scholar
Jones, RW Wesnes, KA Kirby, J Effects of NMDA modulation in scopolamine dementia. Ann. N.Y. Acad. Sci. (Aging Alzheimer's Dis.) 1991 241–244.
Google Scholar
Fischer, W Bjoerklund, A Chen, K Gage, FH NGF improves spacial memory in aged rodents as a function of age. Neurosci. Lett. 1991 131 135–139.
PubMedGoogle Scholar
Allen, SJ Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus. Neurosci. Lett. 1991 131 135–139.
PubMed Web of Science ®Google Scholar
Geller, AI During, MJ Neve, RL Molecular analysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vector. Neurosci. Lett. 1991 14 428–432.
Google Scholar
Richards, S-J The neuropathology of Alzheimer's disease investigated by transplantation of mouse Trisomy 16 hippocampal tissue. TINS 1991 14 334–338.
PubMed Web of Science ®Google Scholar
Dunnett, S Cholinergic grafts, memory and aging. TINS 1991 14 371–376.
PubMed Web of Science ®Google Scholar
Lindvall, O Prospects of transplantation in human neurodegenerative disease. TINS 1991 14 376–384.
PubMed Web of Science ®Google Scholar
Advokat, C Pellegrin, AI Exctatory amino acids and memory: Evidence from research on Alzheimer's disease. Neurosci. Biobehav. Rev. 1992 16 13–24.
PubMed Web of Science ®Google Scholar
Barker, R Substance P and neurodegenerative disorders. A speculative review. Neuropeptides (Edinburgh) 1991 20 73–78.
PubMed Web of Science ®Google Scholar
Freeman, GB Mykytyn, V Gibson, GE Differential alteration of dopamine, acetylcholine, and glutamate release during anoxia and/or 3,4-diaminopyridine treatment. Neurochemical Res. 1987 12 1019–1027.
PubMed Web of Science ®Google Scholar
Jucker, M Oettinger, R Improvement of radial maze patrolling in senescent rats by 3,4-diaminopyridine. Experientia 1986 42 700.
Google Scholar
Clipsin as a therapeutic aid to the treatment of Alzheimer's disease. Curr. Opin. Thera. Patents. 1992 2 4 500–501.
Google Scholar
Hardy, JA Higgins, GA Alzheimer's disease: The amyloid cascade hypothesis. Science 1992 256 184–185.
PubMed Web of Science ®Google Scholar

References to Patent literature

Hoechst-Roussel EP -468104-A.
Google Scholar
Hoechst-Roussel EP -471296-A.
Google Scholar
Hoechst-Roussel EP -471298-A.
Google Scholar
Hoechst-Roussel EP -477903-A.
Google Scholar
Hoechst-Roussel EP -484573-A.
Google Scholar
Hoechst-Roussel US 5106856.
Google Scholar
Eisai Co EP -468187-A.
Google Scholar
Eisai Co US 4895841.
Google Scholar
Biorex-Kutato-Fejlesz WO 9200737.
Google Scholar
Pfizer Inc WO 9200961.
Google Scholar
SS Pharm Co EP -481429-A.
Google Scholar
Takeda EP -487071-A.
Google Scholar
Mediolanum Farm SpA EP -486958-A.
Google Scholar
Mayo Fnd for Med Ed & Res US 5104880.
Google Scholar
Sigma-Tau Ind Farm Riunite SpA EP -488965-A.
Google Scholar
Hoechst-Roussel WO 9200072.
Google Scholar
Hoechst-Roussel US 5100891.
Google Scholar
Boehringer Inhelheim Inst WO 9200297.
Google Scholar
Novo Nordisk AS WO 9203430.
Google Scholar
Novo Nordisk AS WO 9203433.
Google Scholar
Beecham Group Plc WO 9203435.
Google Scholar
Beecham Group Plc WO 9206959.
Google Scholar
Sumrtomo Pharm Co Ltd EP -476933-A.
Google Scholar
American Home Product Corp US 5099333.
Google Scholar
Nippon Shinyakau Co Ltd WO 9204333.
Google Scholar
Gyogyszerkutato Intezet KV WO 9207854.
Google Scholar
Adir & Co EP -485844-A.
Google Scholar
Merck Sharp & Dohme EP -473442-A.
Google Scholar
Beecham Group Inc WO 9204323.
Google Scholar
DuPont Merck Pharm Co WO 9200760.
Google Scholar
ER Squibb & Sons Inc EP -481207-A.
Google Scholar
Merck Sharp & Dohme GB -2245564-A.
Google Scholar
Warner-Lambert Co WO 9207855.
Google Scholar
Warner-Lambert Co US 5075305.
Google Scholar
Mitsui Petrochem Ind Ltd WO 9200970.
Google Scholar
Harvard College WO 9203474.
Google Scholar
New York University WO 9203374.
Google Scholar
Dana Farber Cancer Institute WO 9207945.
Google Scholar
University of California WO 9205272.
Google Scholar
University of California US 5064557.
Google Scholar
Children's Medical Center Corp WO 9202248.
Google Scholar
Kyowa Hakko Kogyo Co Ltd WO 9206976.
Google Scholar
Elan Corp plc EP -484186-A.
Google Scholar
Children's Medical Center Corp WO 9207562.
Google Scholar
Ludke, HW WO 9201455.
Google Scholar
Adir & Co EP -470317-A.
Google Scholar
Depha Team Srl WO 9206980.
Google Scholar
Adir & Co EP -486386-A.
Google Scholar
Biosources Genetics Corp WO 9207580.
Google Scholar
El DuPont de Nemours & Co WO 9200374.
Google Scholar
Boston University WO 9203542.
Google Scholar
Case Western Reserve University WO 9200521.
Google Scholar
Royal Institute for the Advancement of Learning US 5100645.
Google Scholar
Athena Neurosciences Inc WO 9207068.
Google Scholar
Upjohn Co WO 9206187.
Google Scholar
Hoechst-Roussel EP -489379-A.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Patent Update: Agents for the Treatment of Alzheimer's Disease: Recent Patent Advances January to June, 1992

References to Primary Literature

References to Patent literature

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Patent Update: Agents for the Treatment of Alzheimer's Disease: Recent Patent Advances January to June, 1992

References to Primary Literature

References to Patent literature

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date